scholarly journals Lack of retinoid acid receptor-related orphan receptor alpha accelerates and melatonin supplementation prevents testicular aging

Aging ◽  
2020 ◽  
Vol 12 (13) ◽  
pp. 12648-12668
Author(s):  
Ramy K. A. Sayed ◽  
Doaa M. Mokhtar ◽  
Marisol Fernández-Ortiz ◽  
José Fernández-Martínez ◽  
Paula Aranda-Martínez ◽  
...  
2016 ◽  
Vol 80 ◽  
pp. 17-23 ◽  
Author(s):  
Lei Xiao ◽  
Zihui Zhang ◽  
Xiaoqin Luo ◽  
Haixia Yang ◽  
Fan Li ◽  
...  

PLoS ONE ◽  
2013 ◽  
Vol 8 (4) ◽  
pp. e60111 ◽  
Author(s):  
Nathalie Acevedo ◽  
Annika Sääf ◽  
Cilla Söderhäll ◽  
Erik Melén ◽  
Jami Mandelin ◽  
...  

1996 ◽  
Vol 271 (23) ◽  
pp. 13515-13522 ◽  
Author(s):  
Martin Missbach ◽  
Bruno Jagher ◽  
Ivo Sigg ◽  
Sepideh Nayeri ◽  
Carsten Carlberg ◽  
...  

2006 ◽  
Vol 7 (3) ◽  
pp. 254
Author(s):  
F. Osaki ◽  
H. Takata ◽  
T. Suehiro ◽  
M. Inoue ◽  
K. Arii ◽  
...  

2020 ◽  
Author(s):  
Shahan Mamoor

Treatment with trastuzumab has been associated with an increased risk of central nervous system metastasis in patients with human breast cancer (1-5). We performed unbiased transcriptome profiling of primary tumors of patients treated with trastuzumab using published microarray and multiplexed gene expression datasets (6, 7) to understand the transcriptional makeup of breast tumors in the trastuzumab-treated patients. We found that the retinoid acid receptor alpha was among the genes most differentially expressed in the primary tumors of patients treated with trastuzumab; retinoid acid receptor alpha was expressed at significantly higher levels in tumors from patients with trastuzumab as compared to those not treated with trastuzumab. Increased retinoic acid receptor alpha expression is known to confer tamoxifen resistance to human breast cancers (8), and RARA expression is higher in tumors with higher proliferative capacity (9), suggesting that trastuzumab could contribute to resistance to endocrine therapy.


Sign in / Sign up

Export Citation Format

Share Document